Cellectis - ADR

XNAS:CLLS   4:00:00 PM EDT
3.82
+0.22 (+6.11%)
4:04:47 PM EDT: $3.82 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)276.28M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$13.39 Million
Adjusted EPS-$0.20
See more estimates
10-Day MA$3.76
50-Day MA$4.04
200-Day MA$3.27
See more pivots

Cellectis - ADR Stock, XNAS:CLLS

8, rue de la Croix Jarry, Paris, Ile-de-France 75013
France
Phone: +33.1.81.69.16.00
Number of Employees: 222
http://www.cellectis.com

Description

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and Andr�© Choulika on February 20, 1999 and is headquartered in Paris, France.